Gemini Bio to Distribute Celartia Products in the United States
January 8, 2020
WEST SACRAMENTO, CA, and COLUMBUS, OH – Gemini Bioproducts, LLC (“Gemini”), a leading supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced a distribution agreement with Celartia, Inc. Effective immediately, customers can now purchase Celartia’s line of closed, single-use cell [...]
January 8, 2020
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and interpretation intended both for Direct To Consumers and larger scale Life Science industry projects. With the steps taken, Dante [...]
Single Cell Genome Sequencing Company BioSkryb Raises $11.5M in Seed Funding Round
January 8, 2020
DURHAM – BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced it raised $11.5 million in new funding. This Seed round was led by venture capital firm Anzu Partners and included the law firm Wilson Sonsini Goodrich & Rosati. The funding will accelerate BioSkryb’s product roadmap [...]
January 7, 2020
Quality Immune Checkpoint Proteins Release by Beta Lifescience for the Month of January 2020 FIREFILED, N.J. -- Beta Lifescience, a world leading biotech company based in NJ, USA, announces that scientists in the field of cancer immunotherapy, immune checkpoint, targeted therapy, etc. now have access to the quality immune checkpoint protein products through the company's newly launched website. Immune checkpoints refer to [...]
January 7, 2020
Track the health of cell cultures without removing them from the incubator The OLYMPUS Provi CM20 incubation monitoring system* provides quantitative data about the health of cell cultures while they are in the incubator. The system periodically scans the cultures, counts the number of cells, determines confluency and wirelessly communicates the data to a tablet [...]
Shoreline Biome announces international distribution partnership in Japan
January 7, 2020
FARMINGTON, Conn.— Shoreline Biome, a microbiome research company based here that develops tools for characterizing microbiome populations down to the strain level, has announced a distribution partnership with TOMY Digital Biology Co., Ltd., a leading Japanese biotech organization. TOMY provides high-quality instruments and services to industry segments including biotechnology, biological engineering, medical science, and food [...]
Cover open beakers and bottles securely with a colorful, stretchable lid
January 7, 2020
KIMBLE® Silicon Lids protect precious samples on a wide range of laboratory vessels while adding a splash of color to your lab MILLVILLE, NJ – Using aluminum foil or plastic wrap to cap beakers and flasks has always been a quick fix with questionable effectiveness. The new KIMBLE® Silicone Lids stretch and conform to beaker tops for [...]
CytomX Therapeutics Deploys Genedata Bioprocess
January 7, 2020
CytomX implements off-the-shelf Genedata workflow platform to accelerate development and manufacture of proprietary biotherapeutic modalities for cancer treatment SAN FRANCISCO (PRWEB) -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, has licensed Genedata Bioprocess® to act as an integrated workflow backbone for its [...]
January 7, 2020
License agreement expands New England Biolabs’ rights to use and sell CRISPR/Cas9 reagents and tools DUBLIN, Ireland, and Ipswich MA, USA : ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with New England Biolabs (NEB®), [...]
Redesign Science and OpenEye Scientific announce strategic partnership
January 7, 2020
Partnership will advance both firms' positions in the field of molecular dynamics-based drug discovery NEW YORK and SANTA FE, N.M. -- Redesign Science and OpenEye Scientific are pleased to announce that they have entered into a strategic partnership to integrate OpenEye's pioneering Orion computational platform into Redesign's drug discovery platform. The practice of drug discovery has radically transformed [...]
